News & Updates

19 नवंबर 2012

Ceva announces scientific breakthrough with the launch of Vectormune® AI >

Vectormune® AI a new generation vaccine for the control of Avian Influenza.

30 अक्तूबर 2012

AXA Private Equity provides additional financing to support the development of Ceva >

AXA Private Equity, the leading European diversified private equity firm, announces today that it is providing €100 million of additional financing to support the development of Ceva.

7 सितंबर 2012

Ceva launches CARDALIS® for dogs with heart failure >

A powerful dual treatment in a single tablet

6 अगस्त 2012

The Perfect Pair is now available >

A great innovation in the protection against Newcastle and Gumboro Diseases

24 जुलाई 2012

Mid-year results : Innovation drives Ceva’s growth >

Double-digit growth confirms long term upward trend

16 जुलाई 2012

Ceva will launch the “Perfect Pair” for hatchery vaccination at World Poultry Congress >

Great innovation to be launched at 24th WPC in Brazil, August 5-9 2012

24 अप्रैल 2012

Ceva organized 2nd Swine Reproduction Symposium >

Ceva Santé Animale gathers 150 experts from 18 countries in swine reproduction symposium

11 अप्रैल 2012

Ceva sponsors 8th International Symposium on Avian Influenza >

Innovation in poultry vaccines and solutions reaches beyond animal health

10 अप्रैल 2012

Ceva develops Vectormune© HVT AIV vaccine to combat Avian Influenza >

USDA approval announced at 8th International Symposium on Avian Influenza

16 मार्च 2012

New commercial licenses for viral vaccine production >

Ceva takes commercial license for ProBioGen’s AGE1.CR® Cell Line for viral vaccine production

Back to top